Журнал "Гастроэнтерология" Том 58, №2, 2024
Вернуться к номеру
Indicators of the hemostasis system in patients with nonalcoholic fatty liver disease with an immune response to SARS-CoV-2
Авторы: V.I. Didenko, I.A. Klenina, O.M. Tatarchuk, V.B. Yagmur, S.L. Melanich, O.P. Petishko, K.A. Ruban
SI “Institute of Gastroenterology of the NAMS of Ukraine”, Dnipro, Ukraine
Рубрики: Гастроэнтерология
Разделы: Медицинские форумы
Версия для печати
Purpose: to determine the features of hemostasis in nonalcoholic fatty liver disease (NAFLD) in patients with an immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Materials and methods. Thirty-seven patients with NAFLD were under observation, and immunoglobulins G to SARS-CoV-2 were detected in them. Group I consisted of 19 patients who did not suffer from COVID-19. Group II included 18 patients with COVID-19 confirmed by a polymerase chain reaction. Patients of groups I and II were vaccinated against coronavirus. Clinical symptoms, the state of hemostasis in the vascular-platelet link, the state of coagulation, the content of fibrinogen and ...